Sands K E, Bates D W, Lanken P N, Graman P S, Hibberd P L, Kahn K L, Parsonnet J, Panzer R, Orav E J, Snydman D R, Black E, Schwartz J S, Moore R, Johnson B L, Platt R
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass, USA.
JAMA. 1997 Jul 16;278(3):234-40.
Sepsis syndrome is a leading cause of mortality in hospitalized patients. However, few studies have described the epidemiology of sepsis syndrome in a hospitalwide population.
To describe the epidemiology of sepsis syndrome in the tertiary care hospital setting.
Prospective, multi-institutional, observational study including 5-month follow-up.
Eight academic tertiary care centers.
Each center monitored a weighted random sample of intensive care unit (ICU) patients, non-ICU patients who had blood cultures drawn, and all patients who received a novel therapeutic agent or who died in an emergency department or ICU. Sepsis syndrome was defined as the presence of either a positive blood culture or the combination of fever, tachypnea, tachycardia, clinically suspected infection, and any 1 of 7 confirmatory criteria. Estimates of total cases expected annually were extrapolated from the number of cases, the period of observation, and the sampling fraction.
From January 4, 1993, to April 2, 1994, 12759 patients were monitored and 1342 episodes of sepsis syndrome were documented. The extrapolated, weighted estimate of hospitalwide incidence (mean+/-95% confidence limit) of sepsis syndrome was 2.0+/-0.16 cases per 100 admissions, or 2.8+/-0.17 per 1000 patient-days. The unadjusted attack rate for sepsis syndrome between individual centers differed by as much as 3-fold, but after adjustment for institutional differences in organ transplant populations, variation from the expected number of cases was reduced to 2-fold and was not statistically significant overall. Patients in ICUs accounted for 59% of total extrapolated cases, non-ICU patients with positive blood cultures for 11%, and non-ICU patients with negative blood cultures for 30%. Septic shock was present at onset of sepsis syndrome in 25% of patients. Bloodstream infection was documented in 28%, with gram-positive organisms being the most frequent isolates. Mortality was 34% at 28 days and 45% at 5 months.
Sepsis syndrome is common in academic hospitals, although the overall rates vary considerably with the patient population. A substantial fraction of cases occur outside ICUs. An understanding of the hospitalwide epidemiology of sepsis syndrome is vital for rational planning and treatment of hospitalized patients with sepsis syndrome, especially as new and expensive therapeutic agents become available.
脓毒症综合征是住院患者死亡的主要原因。然而,很少有研究描述全院范围内脓毒症综合征的流行病学情况。
描述三级医疗医院环境中脓毒症综合征的流行病学情况。
前瞻性、多机构、观察性研究,包括5个月的随访。
8个学术性三级医疗中心。
每个中心监测重症监护病房(ICU)患者的加权随机样本、接受血培养的非ICU患者,以及所有接受新型治疗药物或在急诊科或ICU死亡的患者。脓毒症综合征定义为血培养阳性,或伴有发热、呼吸急促、心动过速、临床疑似感染以及7项确认标准中的任何一项。每年预期的总病例数是根据病例数、观察期和抽样比例推算出来的。
从1993年1月4日至1994年4月2日,共监测了12759例患者,记录到1342例脓毒症综合征发作。推算出的全院脓毒症综合征发病率(均值±95%置信区间)为每100例入院患者2.0±0.16例,或每1000患者日2.8±0.17例。各中心之间脓毒症综合征的未调整发病率相差高达3倍,但在对器官移植人群的机构差异进行调整后,与预期病例数的差异降至2倍,总体上无统计学意义。ICU患者占推算总病例数的59%,血培养阳性的非ICU患者占11%,血培养阴性的非ICU患者占30%。25%的患者在脓毒症综合征发作时出现感染性休克。28%的患者有血流感染记录,革兰氏阳性菌是最常见的分离菌。28天死亡率为34%,5个月死亡率为45%。
脓毒症综合征在学术性医院中很常见,尽管总体发病率因患者群体而异。相当一部分病例发生在ICU之外。了解全院范围内脓毒症综合征的流行病学情况对于合理规划和治疗脓毒症综合征住院患者至关重要,尤其是在有新的昂贵治疗药物可用的情况下。